Search

Your search keyword '"Dello Iacovo, Filippo"' showing total 6 results
Start Over Author "Dello Iacovo, Filippo"
6 results on '"Dello Iacovo, Filippo"'

1. Interobserver variability in cytopathology: How much do we agree?

Author

Acanfora, Gennaro, Carillo, Anna Maria, Dello Iacovo, Filippo, Salatiello, Maria, Pisapia, Pasquale, Bellevicine, Claudio, Troncone, Giancarlo, and Vigliar, Elena

Subjects
CELLULAR pathology, SALIVARY glands, DIFFERENTIAL diagnosis
Abstract

Interobserver variability remains a major challenge for cytopathologists despite the development of standardized reporting and classification systems. Indeed, whereas moderate‐to‐good interobserver agreement is generally achievable when the differential diagnosis between benign and malignant entities is straightforward, high levels of variability make the diagnostic interpretation of atypical and suspicious samples not consistent. This review explores the landscape of interobserver agreement in cytopathology across different anatomical sites. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

3. COVID‐19 pandemic impact on cytopathology practice in the post‐lockdown period: An international, multicenter study

Author

Vigliar, Elena, primary, Pisapia, Pasquale, additional, Dello Iacovo, Filippo, additional, Alcaraz‐Mateos, Eduardo, additional, Alì, Greta, additional, Ali, Syed Z., additional, Baloch, Zubair W., additional, Bellevicine, Claudio, additional, Bongiovanni, Massimo, additional, Botsun, Pavlina, additional, Bruzzese, Dario, additional, Bubendorf, Lukas, additional, Büttner, Reinhard, additional, Canberk, Sule, additional, Capitanio, Arrigo, additional, Casadio, Chiara, additional, Cazacu, Eugeniu, additional, Cochand‐Priollet, Beatrix, additional, D’Amuri, Alessandro, additional, Davis, Katelynn, additional, Eloy, Catarina, additional, Engels, Marianne, additional, Fadda, Guido, additional, Fontanini, Gabriella, additional, Fulciniti, Franco, additional, Hofman, Paul, additional, Iaccarino, Antonino, additional, Ieni, Antonio, additional, Jiang, Xiaoyin Sara, additional, Kakudo, Kennichi, additional, Kern, Izidor, additional, Kholova, Ivana, additional, Linton McDermott, Kathryn M., additional, Liu, Chinhua, additional, Lobo, Anandi, additional, Lozano, Maria D., additional, Malapelle, Umberto, additional, Maleki, Zahra, additional, Michelow, Pamela, additional, Mikula, Michael W., additional, Musayev, Jamal, additional, Özgün, Gonca, additional, Oznur, Meltem, additional, Peiró Marqués, Francisca Maria, additional, Poller, David, additional, Pyzlak, Michal, additional, Robinson, Betsy, additional, Rossi, Esther Diana, additional, Roy‐Chowdhuri, Sinchita, additional, Saieg, Mauro, additional, Savic Prince, Spasenija, additional, Schmitt, Fernando C., additional, Seguí Iváñez, Francisco Javier, additional, Štoos‐Veić, Tajana, additional, Sulaieva, Oksana, additional, Sweeney, Brenda J., additional, Tuccari, Giovanni, additional, van Velthuysen, Marie‐Louise, additional, VanderLaan, Paul A., additional, Vielh, Philippe, additional, Viola, Patrizia, additional, Voorham, Quirinus J. M., additional, Weynand, Birgit, additional, Zeppa, Pio, additional, Faquin, William C., additional, Pitman, Martha Bishop, additional, and Troncone, Giancarlo, additional

Published
2022
Full Text
View/download PDF

5. Cytopathology Practice in the COVID-19 Era: Focus on Sample Workload

Author

Umberto Malapelle, Giancarlo Troncone, Pasquale Pisapia, Caterina De Luca, Filippo Dello Iacovo, Antonino Iaccarino, Claudio Bellevicine, Elena Vigliar, Iaccarino, Antonino, Dello Iacovo, Filippo, Pisapia, Pasquale, De Luca, Caterina, Malapelle, Umberto, Bellevicine, Claudio, Troncone, Giancarlo, and Vigliar, Elena

Subjects
medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), business.industry, Outbreak, COVID-19, 030209 endocrinology & metabolism, Workload, Sample (statistics), 03 medical and health sciences, Biosafety, 0302 clinical medicine, cytopathology, Cytopathology, FNA, 030220 oncology & carcinogenesis, Pandemic, medicine, Pathology, cancer, RB1-214, Sampling (medicine), screening programs, Intensive care medicine, business
Abstract

Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak was declared a pandemic, the magnitude of coronavirus disease 2019 (COVID-19) has continued to grow, putting an unprecedented strain on all medical fields. Its effects on cytopathology workloads have been dramatic. Indeed, despite the implementation of several laboratory biosafety recommendations, cytological screening activities and cytological sampling of patients at low risk of malignancy have been postponed to limit the risk of contagion and to lessen the strain on overwhelmed hospital facilities. In this scenario, a drastic reduction in the total number of cytological specimens has been observed worldwide. This review summarizes the current evidence of the impact of the COVID-19 pandemic on cytopathology practice by focusing on its impact on cytological sample workload.

Published
2021

6. COVID-19 pandemic impact on cytopathology practice in the post-lockdown period: An international, multicenter study

Author

Elena Vigliar, Pasquale Pisapia, Filippo Dello Iacovo, Eduardo Alcaraz‐Mateos, Greta Alì, Syed Z. Ali, Zubair W. Baloch, Claudio Bellevicine, Massimo Bongiovanni, Pavlina Botsun, Dario Bruzzese, Lukas Bubendorf, Reinhard Büttner, Sule Canberk, Arrigo Capitanio, Chiara Casadio, Eugeniu Cazacu, Beatrix Cochand‐Priollet, Alessandro D’Amuri, Katelynn Davis, Catarina Eloy, Marianne Engels, Guido Fadda, Gabriella Fontanini, Franco Fulciniti, Paul Hofman, Antonino Iaccarino, Antonio Ieni, Xiaoyin Sara Jiang, Kennichi Kakudo, Izidor Kern, Ivana Kholova, Kathryn M. Linton McDermott, Chinhua Liu, Anandi Lobo, Maria D. Lozano, Umberto Malapelle, Zahra Maleki, Pamela Michelow, Michael W. Mikula, Jamal Musayev, Gonca Özgün, Meltem Oznur, Francisca Maria Peiró Marqués, David Poller, Michal Pyzlak, Betsy Robinson, Esther Diana Rossi, Sinchita Roy‐Chowdhuri, Mauro Saieg, Spasenija Savic Prince, Fernando C. Schmitt, Francisco Javier Seguí Iváñez, Tajana Štoos‐Veić, Oksana Sulaieva, Brenda J. Sweeney, Giovanni Tuccari, Marie‐Louise van Velthuysen, Paul A. VanderLaan, Philippe Vielh, Patrizia Viola, Quirinus J. M. Voorham, Birgit Weynand, Pio Zeppa, William C. Faquin, Martha Bishop Pitman, Giancarlo Troncone, Vigliar, Elena, Pisapia, Pasquale, Dello Iacovo, Filippo, Alcaraz-Mateos, Eduardo, Alì, Greta, Ali, Syed Z, Baloch, Zubair W, Bellevicine, Claudio, Bongiovanni, Massimo, Botsun, Pavlina, Bruzzese, Dario, Bubendorf, Luka, Büttner, Reinhard, Canberk, Sule, Capitanio, Arrigo, Casadio, Chiara, Cazacu, Eugeniu, Cochand-Priollet, Beatrix, D'Amuri, Alessandro, Davis, Katelynn, Eloy, Catarina, Engels, Marianne, Fadda, Guido, Fontanini, Gabriella, Fulciniti, Franco, Hofman, Paul, Iaccarino, Antonino, Ieni, Antonio, Jiang, Xiaoyin Sara, Kakudo, Kennichi, Kern, Izidor, Kholova, Ivana, Linton McDermott, Kathryn M, Liu, Chinhua, Lobo, Anandi, Lozano, Maria D, Malapelle, Umberto, Maleki, Zahra, Michelow, Pamela, Mikula, Michael W, Musayev, Jamal, Özgün, Gonca, Oznur, Meltem, Peiró Marqués, Francisca Maria, Poller, David, Pyzlak, Michal, Robinson, Betsy, Rossi, Esther Diana, Roy-Chowdhuri, Sinchita, Saieg, Mauro, Savic Prince, Spasenija, Schmitt, Fernando C, Seguí Iváñez, Francisco Javier, Štoos-Veić, Tajana, Sulaieva, Oksana, Sweeney, Brenda J, Tuccari, Giovanni, van Velthuysen, Marie-Louise, Vanderlaan, Paul A, Vielh, Philippe, Viola, Patrizia, Voorham, Quirinus J M, Weynand, Birgit, Zeppa, Pio, Faquin, William C, Pitman, Martha Bishop, Troncone, Giancarlo, and Pathology

Subjects
Cancer Research, cancer screening program, coronavirus disease 2019 (COVID-19), cytopathology, fine-needle aspiration, malignancy rate, Communicable Disease Control, Humans, Pandemics, SARS-CoV-2, COVID-19, Neoplasms, delež malignosti, diagnostični presejalni programi, lung -- pathology -- cytology, neoplasms, diagnostic screening programs, SDG 3 - Good Health and Well-being, novotvorbe -- statistika, tankoigelna biopsija, pljuča -- patologija -- citologija, udc:616, early detection of cancer, zgodnje odkrivanje raka, citopatologija, covid-19, Oncology, fine-needle biopsy
Abstract

Background: In a previous worldwide survey, the authors showed a drastic reduction in the number of cytological specimens processed during the coronavirus disease 2019 “lockdown” period along with an increase in malignancy rates. To assess the continued impact of the pandemic on cytological practices around the world, they undertook a second follow-up worldwide survey collecting data from the post-lockdown period (2020). Methods: Participants were asked to provide data regarding their cytopathology activity during the first 12 weeks of their respective national post-lockdown period (2020), which ranged from April 4 to October 31. Differences between the post-lockdown period and the corresponding 2019 period were evaluated, and the authors specifically focused on rates of malignant diagnoses. Results: A total of 29 respondents from 17 countries worldwide joined the survey. Overall, a lower number of cytological specimens (n = 236,352) were processed in comparison with the same period in 2019 (n = 321,466) for a relative reduction of 26.5%. The overall malignancy rate showed a statistically significant increase (12,442 [5.26%] vs 12,882 [4.01%]; P

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results